All AbMole products are for research use only, cannot be used for human consumption.
DOTA-LM3 TFA is a somatostatin receptor (SSTR) antagonist.
| Molecular Weight | 1664.18 |
| Formula | C71H94ClF3N16O21S2 |
| Form | Solid |
| Solubility (25°C) | Water 100 mg/mL (Need ultrasonic) |
| Storage | Store at ≤ -20°C, protect from light, dry, sealed |
| Related Somatostatin Receptor Products |
|---|
| Pasireotide
Pasireotide is a somatostatin analog with a 40-fold increased affinity to somatostatin receptor 5 compared to other somatostatin analogs. |
| Octreotide Acetate
Octreotide acetate(SMS 201995 acetate) is a long-acting octapeptide with pharmacologic actions mimicking those of the natural hormone somatostatin. |
| Cyclosomatostatin acetate
Cyclosomatostatin acetate is a potent somatostatin (SST) receptor antagonist. Cyclosomatostatin acetate can inhibit somatostatin receptor type 1 (SSTR1) signaling and decreases cell proliferation, ALDH+ cell population size and sphere-formation in colorectal cancer (CRC) cells. |
| FK962
FK962 is an enhancer of somatostatin release, exerts cognitive-enhancing actions. |
| Lanreotide
Lanreotide is a somatostatin analogue, acts as an inhibitor of growth hormone (GH). |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
